MSI2 and B-cell non-Hodgkin lymphoma: MSI2 plays a key role in hematopoietic stem cell activation, myeloid leukemia, and chronic lymphocytic leukemia (CLL) and its expression correlates with poor prognosis in multiple hematological malignancies, but its role in B-cell lymphoma is not currently known14–19.